Last reviewed · How we verify
Traveler's diarrhea
Approved treatments
- Imodium · Johnson & Johnson (McNeil Consumer Healthcare)
Peripheral mu-opioid receptor agonist that slows intestinal motility and increases fluid absorption without crossing the blood-brain barrier.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Traveler's diarrhea patent landscape — cliff calendar, originator estates, attackable patents
- Traveler's diarrhea treatment landscape brief
- Traveler's diarrhea treatment updates RSS
Frequently asked questions about Traveler's diarrhea
What drugs treat Traveler's diarrhea?
Tracked treatments include Imodium.
What is the treatment for Traveler's diarrhea?
Standard treatment for Traveler's diarrhea includes Imodium. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Traveler's diarrhea patent cliff · Traveler's diarrhea CI report
- Treatment: Imodium · Johnson & Johnson (McNeil Consumer Healthcare)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing